Skip to main content
Daily Report

Daily Sepsis Research Analysis

02/27/2025
3 papers selected
3 analyzed

Three studies advance precision care in sepsis and critical illness. A cystatin C–guided cefepime dosing nomogram doubled predicted PK/PD target attainment without increasing toxic exposure. A Taiwanese population-specific genetic risk score markedly improved 28-day mortality prediction, and a stacked ensemble machine-learning model accurately predicted AKI in acute pancreatitis with sepsis with external validation.

Summary

Three studies advance precision care in sepsis and critical illness. A cystatin C–guided cefepime dosing nomogram doubled predicted PK/PD target attainment without increasing toxic exposure. A Taiwanese population-specific genetic risk score markedly improved 28-day mortality prediction, and a stacked ensemble machine-learning model accurately predicted AKI in acute pancreatitis with sepsis with external validation.

Research Themes

  • Precision dosing and therapeutic drug monitoring in critical illness
  • Genomic risk stratification tailored to population specificity
  • Machine learning for early prediction of organ dysfunction in sepsis

Selected Articles

1. Population-specific genetic-risk scores enable improved prediction of mortality within 28 days of sepsis onset: a retrospective Taiwanese cohort study.

73.5Level IIICohort
Journal of intensive care · 2025PMID: 40011956

In a Taiwanese cohort of 1,403 sepsis patients, a population-specific polygenic risk score significantly improved 28-day mortality prediction over clinical-only models (AUROC 0.78 vs 0.61) and outperformed models based on European-identified SNPs. Five SNPs reached genome-wide significance and higher PRS was associated with worse survival.

Impact: Introduces a precision-prognostic tool tailored to population genetics that markedly enhances short-term mortality prediction in sepsis. It underscores the importance of population-specific genomic models for clinical risk stratification.

Clinical Implications: If externally validated and operationalized, PRS could augment triage and resource allocation, inform intensity of monitoring and organ support, and enable precision trials. Implementation requires genetic testing infrastructure, ethical safeguards, and cost-effectiveness evaluation.

Key Findings

  • Five SNPs reached genome-wide significance (p < 5e-8) for 28-day mortality after sepsis onset; 86 SNPs were suggestive (p < 1e-5).
  • Adding a Taiwanese population-specific PRS to clinical variables improved discrimination (AUROC 0.78 [0.75–0.80], c-index 0.79 [0.62–0.96]) over clinical-only models (AUROC 0.61 [0.58–0.64], c-index 0.63 [0.45–0.81]).
  • Models based on significant SNPs from prior European studies underperformed in this cohort (AUROC 0.60 [0.58–0.63]), highlighting ethnic specificity.
  • Kaplan–Meier analysis showed higher PRS groups had significantly worse survival.

Methodological Strengths

  • Genome-wide survival analysis with clear primary endpoint (28-day mortality)
  • Direct comparison of PRS-enhanced models versus clinical-only and non-native SNP models
  • Performance quantified with AUROC and c-index with confidence intervals

Limitations

  • Single-population retrospective cohort; generalizability requires external multi-ethnic validation
  • Clinical utility not assessed in a prospective implementation study
  • Potential population stratification and unmeasured confounding

Future Directions: Prospective, multi-ethnic external validation; integration with dynamic clinical data; assessment of decision-analytic impact, equity, and cost-effectiveness; development of practice guidelines for genomic risk use in sepsis.

BACKGROUND: Sepsis is characterized by organ dysfunction as a response to infection and is one of the leading causes of mortality and loss of health. The heterogeneous nature of sepsis, along with ethnic differences in susceptibility, challenges a thorough understanding of its etiology. This study aimed to propose prediction models by leveraging genetic-risk scores and clinical variables that can assist in risk stratification of patients. METHODS: A total of 1,403 patients from Taiwan, diagnosed with sepsis, were utilized. Genome-wide survival analysis was conducted, with death within 28 days from sepsis onset, as the primary event to report significantly associated SNPs. A polygenic risk score (PRS-sepsis) was constructed via clumping and thresholding method which was added to clinical-only models to generate better performing prognostic models for identifying high-risk patients. Kaplan-Meier analysis was conducted using PRS-sepsis. RESULTS: A total of five single-nucleotide-polymorphisms (SNPs) reached genome-wide significance (p < 5e-8), and 86 SNPs reached suggestive significance (p < 1e-5). The prognostic model using PRS-sepsis showed significantly improved performance with c-index [confidence interval (CI)] of 0.79 [0.62-0.96] and area under receiver operating characteristic curve (AUROC) [CI] of 0.78 [0.75-0.80], in comparison to clinical-only prognostic models (c-index [CI] = 0.63 [0.45- 0.81], AUROC [CI] = 0.61 [0.58-0.64]). The ethnic specificity was established for our proposed models by comparing it with models generated using significant SNPs from prior European studies (c-index [CI] = 0.63 [0.42-0.85], AUROC [CI] = 0.60 [0.58-0.63]). Kaplan-Meier plots showed that patient groups with higher PRSs have inferior survival probability compared to those with lower PRSs. CONCLUSIONS: This study proposed genetic-risk models specific for Taiwanese populations that outperformed clinical-only models. Also it established a strong racial-effect on the underlying genetics of sepsis-related mortality. The model can potentially be used in real clinical setting for deciding precise treatment courses for patients at high-risk thereby reducing the possibility of worse outcomes.

2. Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically Ill.

66.5Level IIICohort
Critical care medicine · 2025PMID: 40013864

Using data from 120 critically ill adults with cystatin C and cefepime levels, an eGFRcr-cys and weight-based nomogram doubled the predicted 24-hour 100% fT>MIC target attainment (76% vs 38%; p<0.001) and reduced extreme exposure (fAUC0–24 >900 or <300 mg·hr/L: 7% vs 20%; p=0.004) without markedly increasing overall exposure.

Impact: Provides a pragmatic, precision-dosing tool leveraging cystatin C to optimize beta-lactam PK/PD in critically ill patients, with immediate applicability to antimicrobial stewardship.

Clinical Implications: Adopting eGFRcr-cys–guided initial cefepime dosing can improve early PK/PD target attainment and avoid under- or overexposure that risks treatment failure or neurotoxicity. Hospitals should consider implementing cystatin C testing and integrating the nomogram into prescribing workflows, followed by prospective outcomes evaluation.

Key Findings

  • Nomogram based on eGFRcr-cys and weight predicted 100% fT>MIC at 24h in 76% vs 38% with administered doses (p<0.001).
  • Extreme exposure (fAUC0–24 >900 or <300 mg·hr/L) was reduced with the nomogram (7% vs 20%; p=0.004).
  • Median fAUC0–24 slightly increased with the nomogram (666 vs 612 mg·hr/L; p=0.01), without widening exposure variability.

Methodological Strengths

  • Pharmacokinetic modeling anchored to measured cefepime levels in real ICU patients
  • Clear PK/PD endpoints (100% fT>MIC) and exposure distribution analyses with statistical testing

Limitations

  • Single-center retrospective dataset; simulation-based evaluation without clinical outcomes
  • Requires cystatin C availability and MIC assumptions; external validation needed

Future Directions: Prospective, multicenter implementation trials assessing clinical outcomes (microbiologic cure, neurotoxicity), cost-effectiveness, and integration with therapeutic drug monitoring.

OBJECTIVES: Estimated glomerular filtration rate is more accurate with combined creatinine and cystatin C equations (eGFR cr-cys ) than creatinine alone. This study created and evaluated a cefepime dosing nomogram based on eGFR cr-cys for initial dosing in the critically ill. DESIGN: Pharmacokinetic modeling and simulation study. SETTING: Academic medical center. PATIENTS: Critically ill adults treated with cefepime. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Data from 120 patients with baseline cystatin C and follow-up cefepime levels were used to develop a nomogram based on eGFR cr-cys and weight for initial cefepime dosing. The predicted proportion of patients who achieved a free cefepime concentration above the minimum inhibitory concentration of the organism for 100% of the dosing interval in the first 24 hours (100% ƒT > MIC at 24 hr) was compared between administered doses and those predicted by the nomogram doses. Overall drug exposure was estimated with the free area under the concentration time curve from 0 to 24 hours (ƒAUC 0-24 ) and compared between administered and nomogram doses. Achievement of 100% ƒT > MIC at 24 hours was predicted to be significantly better with the nomogram compared with the administered dose (76% vs. 38%; p < 0.001). The median ƒAUC 0-24 as

3. Predicting the risk of acute kidney injury in patients with acute pancreatitis complicated by sepsis using a stacked ensemble machine learning model: a retrospective study based on the MIMIC database.

65.5Level IIICohort
BMJ open · 2025PMID: 40010820

A stacked ensemble model built from eight algorithms and Boruta-selected features predicted AKI in 1,295 acute pancreatitis patients with sepsis, achieving AUC 0.853 (internal) and 0.802 (external). SHAP explanations supported interpretability, indicating readiness for prospective evaluation and EHR integration.

Impact: Delivers an externally validated, explainable ML model for early AKI risk stratification in a high-risk sepsis subgroup, potentially enabling timely nephroprotective strategies.

Clinical Implications: Embedding the model into ICU workflows could trigger early AKI prevention bundles (hemodynamic optimization, avoidance of nephrotoxins, dose adjustments) and targeted monitoring. Prospective calibration, fairness assessment, and clinical impact evaluation are needed.

Key Findings

  • Among 1,295 patients with acute pancreatitis complicated by sepsis, 68.9% (893) developed AKI.
  • The stacked ensemble (“Multimodel”) achieved AUC 0.853 (95% CI 0.792–0.896) internally and 0.802 (95% CI 0.732–0.861) externally, outperforming single base learners.
  • Boruta feature selection and SHAP explanations enhanced model parsimony and interpretability for clinical use.

Methodological Strengths

  • Internal and external validation with multiple performance metrics (AUC, PR, F1, recall)
  • Model explainability via SHAP and robust feature selection (Boruta)

Limitations

  • Retrospective design with potential coding and selection biases
  • Focused on a specific sepsis subgroup (acute pancreatitis), limiting generalizability
  • Clinical utility and net benefit not tested in prospective deployment

Future Directions: Prospective, randomized or stepped-wedge implementation to assess clinical impact; calibration drift monitoring; multi-center validation; integration with EHR alerts and clinician-in-the-loop design.

OBJECTIVE: This study developed and validated a stacked ensemble machine learning model to predict the risk of acute kidney injury in patients with acute pancreatitis complicated by sepsis. DESIGN: A retrospective study based on patient data from public databases. PARTICIPANTS: This study analysed 1295 patients with acute pancreatitis complicated by septicaemia from the US Intensive Care Database. METHODS: From the MIMIC database, data of patients with acute pancreatitis and sepsis were obtained to construct machine learning models, which were internally and externally validated. The Boruta algorithm was used to select variables. Then, eight machine learning algorithms were used to construct prediction models for acute kidney injury (AKI) occurrence in intensive care unit (ICU) patients. A new stacked ensemble model was developed using the Stacking ensemble method. Model evaluation was performed using area under the receiver operating characteristic curve (AUC), precision-recall (PR) curve, accuracy, recall and F1 score. The Shapley additive explanation (SHAP) method was used to explain the models. MAIN OUTCOME MEASURES: AKI in patients with acute pancreatitis complicated by sepsis. RESULTS: The final study included 1295 patients with acute pancreatitis complicated by sepsis, among whom 893 cases (68.9%) developed acute kidney injury. We established eight base models, including Logit, SVM, CatBoost, RF, XGBoost, LightGBM, AdaBoost and MLP, as well as a stacked ensemble model called Multimodel. Among all models, Multimodel had an AUC value of 0.853 (95% CI: 0.792 to 0.896) in the internal validation dataset and 0.802 (95% CI: 0.732 to 0.861) in the external validation dataset. This model demonstrated the best predictive performance in terms of discrimination and clinical application. CONCLUSION: The stack ensemble model developed by us achieved AUC values of 0.853 and 0.802 in internal and external validation cohorts respectively and also demonstrated excellent performance in other metrics. It serves as a reliable tool for predicting AKI in patients with acute pancreatitis complicated by sepsis.